Page 5 - Weiler Engineering News Today

11/30/21 Pharmaceutical Online Newsletter

11/05/21 Pharmaceutical Online Newsletter

10/29/21 Pharmaceutical Online Newsletter

Drug manufacturers seeking alternative methods for a safe and reliable approach to drug delivery should consider blow-fill-seal technology, as it...

10/21/21 Pharmaceutical Online Newsletter

Continued global efforts to incorporate BFS in the safe and efficient delivery of life-saving vaccines are proof the technology serves as a valuable...

05/27/21 Pharmaceutical Online Newsletter

04.27.21 -- Life Sciences Investment Outlook: Deal-Making Gets Creative     Catching up to the paradigm shift in optimizing, scaling-up, and manufacturing plasmids is crucial for clinical to commercial program success for gene therapies and vaccines. With an increased demand for plasmids for targeted gene therapeutic delivery, partnering with a CDMO equipped with the capacity, expertise, and equipment for plasmid DNA production is critical to ensuring a stabl...

04.20.21 -- FDA Inspections: Are Changes On The Horizon?     To get the most out of data, you must ensure they are findable, accessible, interoperable, and reusable — F.A.I.R. for short. Organizations simply don’t have the infrastructure in place to be able to capture data with context and then store them so that they can be searched and accessed with ease. We’ll explore how you can change that using the F.A.I.R. principles, which have been recognized a...

03.09.21 -- Incorporating Excipients Into QbD Studies For Drug Development -- An Introduction     Orphan drugs are notorious for their high costs and risk factors, which are attributed to smaller patient pools and higher development and launch costs.   Attend this webinar to learn more about key trends that are causing the rise of orphan drug indications, fast-tracking early development phases that will lead to commercial success, and more!     By Brian Ca...